Quarterly report pursuant to Section 13 or 15(d)

License Agreements and Clinical Research Support Agreements (Tables)

v3.7.0.1
License Agreements and Clinical Research Support Agreements (Tables)
 6 Months Ended
Jun. 30, 2017
License Agreement Disclosure [Abstract]  
Research and Development Arrangement, Contract to Perform for Others [Table Text Block]
For the three and six months ended June 30, 2017 and 2016, the Company recorded the following expense in research and development - licenses acquired:
 
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
($ in thousands)
 
2017
 
2016
 
2017
 
2016
 
City of Hope
 
 
 
 
 
 
 
 
 
 
 
 
 
IL-13
 
$
-
 
$
-
 
$
250
 
$
-
 
IV/ICV
 
 
-
 
 
-
 
 
125
 
 
-
 
PSCA
 
 
300
 
 
-
 
 
300
 
 
-
 
HER2
 
 
600
 
 
-
 
 
600
 
 
-
 
CS1
 
 
600
 
 
-
 
 
600
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UCLA
 
 
-
 
 
-
 
 
200
 
 
-
 
Total
 
$
1,500
 
$
-
 
$
2,075
 
$
-